aluates Reports

$ 0.0

Automative

Global Carbapenem-Based Antibiotics Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-33O10379

Global Carbapenem Based Antibiotics Market Research Report 2022

BUY CHAPTERS

Global Carbapenem-Based Antibiotics Market Research Report 2025

Code: QYRE-Auto-33O10379

Report

March 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ACS Dobfar

Daewoong Pharmaceutical Co Ltd

Aurobindo Pharma Ltd.

Gland Pharma Limited

Merck& Co. Inc

Sumitomo Dainippon Pharma Co Ltd

Savior Lifetec

Pfizer Inc

Spero Therapeutics

Iterum Therapeutics plc

Carbapenem-Based Antibiotics Market

The global market for Carbapenem-Based Antibiotics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Carbapenem-Based Antibiotics in Retail Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Carbapenem-Based Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-Based Antibiotics.

The Carbapenem-Based Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carbapenem-Based Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Carbapenem-Based Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Carbapenem-Based Antibiotics Market Report

Report Metric	Details
Report Name	Carbapenem-Based Antibiotics Market
Segment by Type	Meropenem Doripenemu Imipenem Tebipenemu Others
Segment by Application	Retail Pharmacies Online Pharmacies Hospital Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbapenem-Based Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Carbapenem-Based Antibiotics Market report?

Ans: The main players in the Carbapenem-Based Antibiotics Market are ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics

What are the Application segmentation covered in the Carbapenem-Based Antibiotics Market report?

Ans: The Applications covered in the Carbapenem-Based Antibiotics Market report are Retail Pharmacies, Online Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Carbapenem-Based Antibiotics Market report?

Ans: The Types covered in the Carbapenem-Based Antibiotics Market report are Meropenem, Doripenemu, Imipenem, Tebipenemu, Others

Recommended Reports

Carbapenem Antibiotics

Broader Antibiotics Market

Antibiotic Resistance & API

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Meropenem

1.2.3 Doripenemu

1.2.4 Imipenem

1.2.5 Tebipenemu

1.2.6 Others

1.3 Market by Application

1.3.1 Global Carbapenem-Based Antibiotics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Retail Pharmacies

1.3.3 Online Pharmacies

1.3.4 Hospital Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Carbapenem-Based Antibiotics Market Perspective (2020-2031)

2.2 Global Carbapenem-Based Antibiotics Growth Trends by Region

2.2.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Carbapenem-Based Antibiotics Historic Market Size by Region (2020-2025)

2.2.3 Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031)

2.3 Carbapenem-Based Antibiotics Market Dynamics

2.3.1 Carbapenem-Based Antibiotics Industry Trends

2.3.2 Carbapenem-Based Antibiotics Market Drivers

2.3.3 Carbapenem-Based Antibiotics Market Challenges

2.3.4 Carbapenem-Based Antibiotics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Carbapenem-Based Antibiotics Players by Revenue

3.1.1 Global Top Carbapenem-Based Antibiotics Players by Revenue (2020-2025)

3.1.2 Global Carbapenem-Based Antibiotics Revenue Market Share by Players (2020-2025)

3.2 Global Carbapenem-Based Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Carbapenem-Based Antibiotics Revenue

3.4 Global Carbapenem-Based Antibiotics Market Concentration Ratio

3.4.1 Global Carbapenem-Based Antibiotics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-Based Antibiotics Revenue in 2024

3.5 Global Key Players of Carbapenem-Based Antibiotics Head office and Area Served

3.6 Global Key Players of Carbapenem-Based Antibiotics, Product and Application

3.7 Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Carbapenem-Based Antibiotics Breakdown Data by Type

4.1 Global Carbapenem-Based Antibiotics Historic Market Size by Type (2020-2025)

4.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031)

5 Carbapenem-Based Antibiotics Breakdown Data by Application

5.1 Global Carbapenem-Based Antibiotics Historic Market Size by Application (2020-2025)

5.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Carbapenem-Based Antibiotics Market Size (2020-2031)

6.2 North America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)

6.4 North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Carbapenem-Based Antibiotics Market Size (2020-2031)

7.2 Europe Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025)

7.4 Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Carbapenem-Based Antibiotics Market Size (2020-2031)

8.2 Asia-Pacific Carbapenem-Based Antibiotics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025)

8.4 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Carbapenem-Based Antibiotics Market Size (2020-2031)

9.2 Latin America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)

9.4 Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Carbapenem-Based Antibiotics Market Size (2020-2031)

10.2 Middle East & Africa Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025)

10.4 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ACS Dobfar S.p.A

11.1.1 ACS Dobfar S.p.A Company Details

11.1.2 ACS Dobfar S.p.A Business Overview

11.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Introduction

11.1.4 ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.1.5 ACS Dobfar S.p.A Recent Development

11.2 Iterum Therapeutics plc

11.2.1 Iterum Therapeutics plc Company Details

11.2.2 Iterum Therapeutics plc Business Overview

11.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Introduction

11.2.4 Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.2.5 Iterum Therapeutics plc Recent Development

11.3 DAEWOONG PHARMACEUTICAL CO.,LTD

11.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Details

11.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview

11.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Introduction

11.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development

11.4 Aurobindo Pharma Ltd

11.4.1 Aurobindo Pharma Ltd Company Details

11.4.2 Aurobindo Pharma Ltd Business Overview

11.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Introduction

11.4.4 Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.4.5 Aurobindo Pharma Ltd Recent Development

11.5 Gland Pharma Limited

11.5.1 Gland Pharma Limited Company Details

11.5.2 Gland Pharma Limited Business Overview

11.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Introduction

11.5.4 Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.5.5 Gland Pharma Limited Recent Development

11.6 Merck & Co., Inc.

11.6.1 Merck & Co., Inc. Company Details

11.6.2 Merck & Co., Inc. Business Overview

11.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Introduction

11.6.4 Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.6.5 Merck & Co., Inc. Recent Development

11.7 Sumitomo Dainippon Pharma Co., Ltd.

11.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details

11.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview

11.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Introduction

11.7.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development

11.8 Savior Lifetec

11.8.1 Savior Lifetec Company Details

11.8.2 Savior Lifetec Business Overview

11.8.3 Savior Lifetec Carbapenem-Based Antibiotics Introduction

11.8.4 Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.8.5 Savior Lifetec Recent Development

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Details

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Introduction

11.9.4 Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.9.5 Pfizer Inc. Recent Development

11.10 Spero Therapeutics

11.10.1 Spero Therapeutics Company Details

11.10.2 Spero Therapeutics Business Overview

11.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Introduction

11.10.4 Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025)

11.10.5 Spero Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ACS Dobfar

Daewoong Pharmaceutical Co Ltd

Aurobindo Pharma Ltd.

Gland Pharma Limited

Merck& Co. Inc

Sumitomo Dainippon Pharma Co Ltd

Savior Lifetec

Pfizer Inc

Spero Therapeutics

Iterum Therapeutics plc

List of Tables

Table 1. Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Meropenem

Table 3. Key Players of Doripenemu

Table 4. Key Players of Imipenem

Table 5. Key Players of Tebipenemu

Table 6. Key Players of Others

Table 7. Global Carbapenem-Based Antibiotics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Carbapenem-Based Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Carbapenem-Based Antibiotics Market Share by Region (2020-2025)

Table 11. Global Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Carbapenem-Based Antibiotics Market Share by Region (2026-2031)

Table 13. Carbapenem-Based Antibiotics Market Trends

Table 14. Carbapenem-Based Antibiotics Market Drivers

Table 15. Carbapenem-Based Antibiotics Market Challenges

Table 16. Carbapenem-Based Antibiotics Market Restraints

Table 17. Global Carbapenem-Based Antibiotics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Carbapenem-Based Antibiotics Market Share by Players (2020-2025)

Table 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)

Table 20. Ranking of Global Top Carbapenem-Based Antibiotics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Carbapenem-Based Antibiotics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Carbapenem-Based Antibiotics, Headquarters and Area Served

Table 23. Global Key Players of Carbapenem-Based Antibiotics, Product and Application

Table 24. Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Carbapenem-Based Antibiotics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2020-2025)

Table 28. Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2026-2031)

Table 30. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2020-2025)

Table 32. Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2026-2031)

Table 34. North America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Carbapenem-Based Antibiotics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)

Table 49. ACS Dobfar S.p.A Company Details

Table 50. ACS Dobfar S.p.A Business Overview

Table 51. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product

Table 52. ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 53. ACS Dobfar S.p.A Recent Development

Table 54. Iterum Therapeutics plc Company Details

Table 55. Iterum Therapeutics plc Business Overview

Table 56. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product

Table 57. Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 58. Iterum Therapeutics plc Recent Development

Table 59. DAEWOONG PHARMACEUTICAL CO.,LTD Company Details

Table 60. DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview

Table 61. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product

Table 62. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 63. DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development

Table 64. Aurobindo Pharma Ltd Company Details

Table 65. Aurobindo Pharma Ltd Business Overview

Table 66. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product

Table 67. Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 68. Aurobindo Pharma Ltd Recent Development

Table 69. Gland Pharma Limited Company Details

Table 70. Gland Pharma Limited Business Overview

Table 71. Gland Pharma Limited Carbapenem-Based Antibiotics Product

Table 72. Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 73. Gland Pharma Limited Recent Development

Table 74. Merck & Co., Inc. Company Details

Table 75. Merck & Co., Inc. Business Overview

Table 76. Merck & Co., Inc. Carbapenem-Based Antibiotics Product

Table 77. Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 78. Merck & Co., Inc. Recent Development

Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Details

Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview

Table 81. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product

Table 82. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development

Table 84. Savior Lifetec Company Details

Table 85. Savior Lifetec Business Overview

Table 86. Savior Lifetec Carbapenem-Based Antibiotics Product

Table 87. Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 88. Savior Lifetec Recent Development

Table 89. Pfizer Inc. Company Details

Table 90. Pfizer Inc. Business Overview

Table 91. Pfizer Inc. Carbapenem-Based Antibiotics Product

Table 92. Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 93. Pfizer Inc. Recent Development

Table 94. Spero Therapeutics Company Details

Table 95. Spero Therapeutics Business Overview

Table 96. Spero Therapeutics Carbapenem-Based Antibiotics Product

Table 97. Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)

Table 98. Spero Therapeutics Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Carbapenem-Based Antibiotics Picture

Figure 2. Global Carbapenem-Based Antibiotics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Carbapenem-Based Antibiotics Market Share by Type: 2024 VS 2031

Figure 4. Meropenem Features

Figure 5. Doripenemu Features

Figure 6. Imipenem Features

Figure 7. Tebipenemu Features

Figure 8. Others Features

Figure 9. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Carbapenem-Based Antibiotics Market Share by Application: 2024 VS 2031

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Hospital Pharmacies Case Studies

Figure 14. Carbapenem-Based Antibiotics Report Years Considered

Figure 15. Global Carbapenem-Based Antibiotics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Carbapenem-Based Antibiotics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Carbapenem-Based Antibiotics Market Share by Region: 2024 VS 2031

Figure 18. Global Carbapenem-Based Antibiotics Market Share by Players in 2024

Figure 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2024

Figure 21. North America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)

Figure 23. United States Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Carbapenem-Based Antibiotics Market Share by Country (2020-2031)

Figure 27. Germany Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Carbapenem-Based Antibiotics Market Share by Region (2020-2031)

Figure 35. China Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)

Figure 43. Mexico Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Carbapenem-Based Antibiotics Market Share by Country (2020-2031)

Figure 47. Turkey Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. ACS Dobfar S.p.A Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 51. Iterum Therapeutics plc Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 52. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 53. Aurobindo Pharma Ltd Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 54. Gland Pharma Limited Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 55. Merck & Co., Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 56. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 57. Savior Lifetec Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 58. Pfizer Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 59. Spero Therapeutics Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ampicillin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Broad spectrum Antibiotics Market Research Report 2025

Cephalosporin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cephalosporin Antibiotics Market Research Report 2024

Global Alternative to Antibiotics Market Research Report 2024

Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Stopper Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Antibiotics Market Research Report 2025

Global Carbapenemase producing Assay Kit Market Research Report 2025

Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Semi Synthetic Penicillin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibiotic Resistance Market Insights Forecast to 2030

Global Carbapenem Market Insights Forecast to 2030

Global Carbapenem Drugs Market Research Report 2024

Antimicrobial Gauze Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Quinolones Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ceftazidime for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Synthetic Penicillin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Antibiotic Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions